Immunic Press Release
2020-04-22

Immunic, Inc. Reports that IMU-838, a Selective Oral DHODH Inhibitor, Has Demonstrated Preclinical Activity Against SARS-CoV-2 and Explores Plans for a Phase 2 Clinical Trial in COVID-19 Patients

Immunic, Inc. Reports that IMU-838,…
read more
iTeos Press Release
2020-04-03

iTeos Therapeutics Closes $125 Million Series B2 Financing

iTeos Therapeutics Closes $125 Million…
read more
eTheRNA Press Release
2020-03-24

eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

eTheRNA launches an international consortium…
read more
Horama Press Release
2020-03-19

HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies

HORAMA Signs Exclusive License Agreement…
read more
Fund+ Jobs
2020-03-13

Job opening at Fund+ / Internship

Job opening Internship Fund+ is…
read more
Fund+ Jobs
2020-03-13

Job opening at Fund+ / Senior Associate

Job opening Senior Associate Fund+…
read more
Horama Press Release
2020-03-13

HORAMA strengthens its management team with the appointment of Rodolphe Clerval as Chief Business Officer (CBO)

HORAMA strengthens its management team…
read more
iTeos Press Release
2020-02-28

iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

iTeos Therapeutics Initiates Phase 1/2 Study…
read more
Minoryx News article
2020-02-18

Minoryx Therapeutics in the news

Minoryx Therapeutics in the news
read more
iTeos News article
2020-01-31

La Wallonie octroie 15 millions à iTeos

La Wallonie octroie 15 millions…
read more